ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 53 • 2016 ACR/ARHP Annual Meeting

    Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric Observational Study

    Maria Chiara Gerardi1, Alberto Batticciotto2, Rossella Talotta1, Maria Chiara Ditto1, Fabiola Atzeni2 and Piercarlo Sarzi-Puttini1, 1Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy

    Efficacy of Cannabis flos in patients with fibromyalgia: a monocentric observational study   Background/Purpose: Fibromyalgia (FM) is a syndrome characterized by chronic widespread pain, fatigue,…
  • Abstract Number: 54 • 2016 ACR/ARHP Annual Meeting

    Patients with Fibromyalgia in General Have Higher Self-Report Questionnaire Scores Than Patients with Rheumatoid Arthritis: Implications for Clinical Trials and Clinical Research

    Theodore Pincus1, Isabel Castrejón1, Joel Block2 and Nathaniel Cook1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Patients with rheumatoid arthritis (RA) who are included in clinical trials generally are selected for measures indicating high disease activity, such as more than…
  • Abstract Number: 55 • 2016 ACR/ARHP Annual Meeting

    Identification of Endogenous Autoantigens Bound to Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis: A Key Role for Citrulline Residues in Histone 4

    Xiaobo Meng1, Peyman Ezzati1, Irene Smolik2, Carol Hitchon3 and Hani El-Gabalawy4, 1UNIVERSITY OF MANITOBA, WINNIPEG, MB, Canada, 2Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 3University of Manitoba, Winnipeg, MB, Canada, 4University of Manitoba Arthritis Center, Winnipeg, MB, Canada

    Background/Purpose: Anti-Citrullinated Peptides Antibodies (ACPA) aid in rheumatoid arthritis (RA) diagnosis. The nature of autoantigens specifically bound to ACPA immune complex in vivoremains unclear. We…
  • Abstract Number: 56 • 2016 ACR/ARHP Annual Meeting

    A Systems Biology Approach to Investigating Beneficial Effects of Endurance Exercise in Myositis Patients

    Jessica Boehler1,2, Marshall Hogarth3, Matthew Barberio3, Svetlana Ghimbovschi2, Kristy Brown1,2, Li Alemo Munters4, Ingela Loell4, Yi-Wen Chen2,5, Helene Alexanderson6, Ingrid E. Lundberg7 and Kanneboyina Nagaraju5,8, 1Department of Integrative Systems Biology, The George Washington University, Washingtion, DC, 2Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC, 3Research Center for Genetic Medicine, Children's National Medical Center, Washingtion, DC, 4Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Sweden, Stockholm, Sweden, 5Department of Integrative Systems Biology, The George Washington University, Washington, DC, 6Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden, 7Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 8Research Center for Genetic Medicine, Children’s National Medical Center, Washington, DC

    Background/Purpose:  Polymyositis (PM) and dermatomyositis (DM) are skeletal muscle disorders characterized by proximal muscle weakness and inflammation. Recent studies have suggested that endurance exercise improves…
  • Abstract Number: 57 • 2016 ACR/ARHP Annual Meeting

    Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA

    Mukundan Attur1, Sisi Ma2, Jonathan Samuels3, Svetlana Krasnokutsky Samuels4, Hua Zhou2, Jenny Bencardino5, Marc C. Hochberg6, Braxton Mitchell7, Virginia B. Kraus8, Joanne M. Jordan9 and Steven B. Abramson10, 1Rheumatology Research, NYU - Hospital for Joint Diseases, New York, NY, 2Bioinformatics, New York University, New York, NY, 3Rheumatology, NYU - Hospital for Joint Diseases, New York, NY, 4Medicine/Rheumatology, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY, 5Radiology, NYU Langone Medical Center, New York, NY, 6University of Maryland School of Medicine, Baltimore, MD, USA, Baltimore, MD, 7Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, 8Department of Medicine, Duke University Medical Center, Durham, NC, 9Thurston Arthritis Research Center, University of North CArolina at Chapel Hill, Chapel Hill, NC, 10Dept of Rheumatology/Medicine, Hosp for Joint Diseases/NYU, New York, NY

    Background/Purpose: Growing numbers of studies show increased expression in Osteoarthritis (OA) of inflammatory cytokines, such as IL-1β and TNFα, in joint tissues and peripheral blood…
  • Abstract Number: 58 • 2016 ACR/ARHP Annual Meeting

    Detecting Novel Candidate Risk Genes in Rheumatoid Arthritis with Gene-Based Association Testing

    Aleksander Lenert1 and David Fardo2, 1Internal Medicine, Div. of Rheumatology, University of Kentucky, Lexington, KY, 2Biostatistics, College of Public Health, University of Kentucky, Lexington, KY

    Background/Purpose: Rheumatoid arthritis (RA) is driven by immune-system dysfunction with contribution from genetic risk factors. Emerging data from genomewide association studies (GWAS) of single nucleotide…
  • Abstract Number: 59 • 2016 ACR/ARHP Annual Meeting

    Novel Agents for Blocking the Interaction of Immune Complexes with the Activatory FcγRIIIa Receptor

    James Robinson1, Euan Baxter1, Darren Tomlinson2, Richard Foster3, Robin Owen4, Stephanie Win1, Joanne Nettleship5, Christian Tiede2, Jayakanth Kankanala2, Raymond Owens5, Colin Fishwick3, Michael McPherson2 and Ann Morgan6, 1NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 2Astbury Centre, School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom, 3School of Chemistry, University of Leeds, Leeds, United Kingdom, 4Harwell Science and Innovation Campus, Diamond Light Source, Didcot, United Kingdom, 5Research Complex at Harwell, Oxford Protein Production Facility - UK, Oxford, United Kingdom, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, Great Britain

    Background/Purpose: Protein-protein interactions are essential for the control of cellular functions and critical for regulation of the immune system. One example is the binding of…
  • Abstract Number: 60 • 2016 ACR/ARHP Annual Meeting

    A Single Nucleotide Polymorphism of IL6-Receptor Is Associated with Response to Tocilizumab in Rheumatoid Arthritis: Results from Toci and ROC Studies

    Cécile Luxembourger1, Adeline Ruyssen-Witrand2, Yannick Degboé3, Alain G. Cantagrel1, Arnaud CONSTANTIN4, Philippe Gaudin5, Christian Jorgensen6, Jean-Francis Maillefert7, Hubert Marotte Sr.8, Delphine Nigon9, Daniel Wendling10, Jacques-Eric Gottenberg11 and Yves-marie Pers12, 1Rheumatology, Centre Hospitalier Universitaire, Toulouse Purpan, Toulouse, France, 2Rheumatology Center, Purpan University Hospital, Toulouse, France, 3Rheumatology, Rheumatology Center, Purpan University Hospital, Toulouse, France, 4Rheumatology, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France, 5Rheumatology, Grenoble University Hospital, France, Grenoble, France, 6Inserm u844, Unite ImmunoRhumatologie Therapeutique, Montpellier, France, 7Rheumatology, University Hospital, Dijon, France, 8CHU de St Etienne, Service de rhumatologie, St Etienne, France, 9CHU Purpan, Toulouse, France, 10Rheumatology, Besançon university hospital, Besançon, France, 11Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, 12coordination RIC SUD, Montpellier, France

    Background/Purpose: Biological agents (boDMARDs) have modified the therapeutic management of patients with rheumatoid arthritis (RA). However, boDMARDs can induce sustained remission in only 30% of…
  • Abstract Number: 61 • 2016 ACR/ARHP Annual Meeting

    Killer Immunoglobulin-like Receptors Are Associated with Ankylosing Spondylitis

    Aimee Hanson1, International Genetics of Ankylosing Spondylitis Consortium (IGAS)2, Kim-Anh Lê Cao3, Tony J. Kenna4 and Matthew A. Brown2, 1The University of Queensland Diamantina Institute, Translational Research Instiute, Brisbane, Australia, Brisbane, Australia, 2Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Brisbane, Australia, Brisbane, Australia, 3Translational Research Instiute, The University of Queensland Diamantina Institute, Brisbane, Australia, 4Translational Research Institute, Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia

    Background/Purpose: Killer immunoglobulin-like receptors (KIRs) are expressed predominantly on the surface of natural killer (NK) cells and some T-cells and are important in regulating the…
  • Abstract Number: 1 • 2016 ACR/ARHP Annual Meeting

    Factors Predicting Likelihood of Remaining Positive for Rheumatoid Arthritis-Related Autoantibodies Following Autoantibody Screening

    Jill M. Norris1, Elizabeth A. Bemis1, M. Kristen Demoruelle2, Michael Weisman3, Jane H. Buckner4, Peter K. Gregersen5, Ted R Mikuls6, James R. O'Dell6, Richard M. Keating7, Kevin D. Deane8 and V. Michael Holers8, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Feinstein Insititute for Medical Research, Manhasset, NY, 6Rheumatology, University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, Scripps Health, La Jolla, CA, 8Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: RA-related autoantibodies are typically elevated prior to the onset of RA. Screening for autoantibody (aAb) positive individuals is a means to assemble a cohort…
  • Abstract Number: 2 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis (RA)-Related Autoimmunity and Lumbar Bone Mineral Density in a Multi-Ethnic Community-Dwelling Population

    Jan M. Hughes-Austin1, Joachim H. Ix2, Michael H. Criqui3, Ronit Katz4, Matthew Budoff5, Jon T. Giles6, Kiang Liu7 and Darcy S. Majka8, 1Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, 4University of Washington, Seattle, WA, 5Cardiology, Harbor-UCLA Medical Center, Torrance, CA, 6Rheumatology, Columbia University Medical Center, NY, NY, 7Department of Preventive Medicine, Northwestern University, Chicago, IL, 8Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Previous studies suggest that antibodies to citrullinated protein antigens (ACPA) contribute to decreased hand bone mineral density (BMD) in RA-free individuals. No evidence exists…
  • Abstract Number: 3 • 2016 ACR/ARHP Annual Meeting

    The Presence of Rheumatoid Factor Is Associated with Lower Bone Mass in Korean Health Screening Male Subjects without Clinically Apparent Arthritis

    Jiwon Hwang1, Joong Kyong Ahn2, Yeonghee Eun3, Hyemin Jeong3, Eun-Jung Park4, Hyungjin Kim3, Jaejoon Lee3, Eun-Mi Koh3 and Hoon-Suk Cha5, 1Department of Medicine, National Police Hospital, Seoul, Korea, The Republic of, 2Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 4Department of Medicine, Division of Rheumatology, Department of Medicine, Jeju National University Hospital, Jeju University School of Medicine, Jeju, South Korea, 5Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

    Background/Purpose:  Close relationship between the immune and skeletal systems has been recognized through the bone loss in rheumatoid arthritis (RA). Rheumatoid factor (RF) is present…
  • Abstract Number: 4 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis (RA)-Related Joint Symptoms and Thoracic Bone Mineral Density in an RA-Free Community Dwelling Population

    Jan M. Hughes-Austin1, Joachim H. Ix2, Samuel R. Ward3, M. Kristen Demoruelle4, V. Michael Holers5, Jill M. Norris6 and Kevin D. Deane7, 1Orthopaedic Surgery, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Radiology, Orthopaedic Surgery, and Bioengineering, University of California, San Diego, La Jolla, CA, 41775 Aurora Ct, 1775 Aurora Ct, Aurora, CO, 5Rheumatology Division, University of Colorado School of Medicine, Aurora, CO, 6University of Colorado Denver, Aurora, CO, 7Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Osteoporosis, defined by Tscore < -2.5, is one of the main consequences of RA and it appears early in the disease. It is twice…
  • Abstract Number: 5 • 2016 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis and Periodontitis: Association and Characteristics of Chronic Periodontitis

    BEATRIZ RODRIGUEZ-LOZANO1, Jerián González Febles2, Jorge Luis Garnier Rodríguez3, Shashi Dadlani4, Elisa Trujillo-Martin1, Vanesa Hernández Hernández1, Sagrario Bustabad5, Mariano Sanz Alonso2 and Federico Díaz-González1, 1Rheumatology, Hospital Universitario de Canarias, S/C Tenerife, Spain, 2Periodontology, Universidad Complutense de Madrid, Madrid, Spain, 3Odontology, Dental Clinic Garnier, S/C Tenerife, Spain, 4Periodontology, Dental Clinic Garnier, S/C Tenerife, Spain, 5Rheumatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain

    Background/Purpose: Recent clinical-epidemiological data suggest that periodontitis (P) shows higher prevalence in rheumatoid arthritis (RA) patients. However, due to the scarcity of epidemiological studies, the…
  • Abstract Number: 6 • 2016 ACR/ARHP Annual Meeting

    Lower Omega-3 Fatty Acid Biomarkers Are Associated with Inflammatory Arthritis in a Population Positive for Anti-Citrullinated Protein Antibodies

    Ryan W. Gan1, Elizabeth A. Bemis1, M. Kristen Demoruelle2, Kevin D. Deane2, Christopher C. Striebich3, James H. Goddard4, Stacey A. Brake4, Michael J. Clare-Salzler5, V. Michael Holers6 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Division of Rhuematology, University of Colorado School of Medicine, Aurora, CO, 4Nine Health Services, Inc., Denver, CO, 5Experimental Pathology, University of Florida, College of Medicine, Gainesville, FL, 6Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Antibodies to citrullinated protein antigens (ACPA) can be elevated prior to onset of inflammatory arthritis (IA) and RA. However, understanding of factors related to…
  • « Previous Page
  • 1
  • …
  • 1598
  • 1599
  • 1600
  • 1601
  • 1602
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology